{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:08:10Z","timestamp":1792598890511,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 DC017397"],"award-info":[{"award-number":["RO1 DC017397"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vocal fold (VF) fibrosis is a major cause of intractable voice-related disability and reduced quality of life. Excision of fibrotic regions is suboptimal and associated with scar recurrence and\/or further iatrogenic damage. Non-surgical interventions are limited, putatively related to limited insight regarding biochemical events underlying fibrosis, and downstream, the lack of therapeutic targets. YAP\/TAZ integrates diverse cell signaling events and interacts with signaling pathways related to fibrosis, including the TGF-\u03b2\/SMAD pathway. We investigated the expression of YAP\/TAZ following vocal fold injury in vivo as well as the effects of TGF-\u03b21 on YAP\/TAZ activity in human vocal fold fibroblasts, fibroblast-myofibroblast transition, and TGF-\u03b2\/SMAD signaling. Iatrogenic injury increased nuclear localization of YAP and TAZ in fibrotic rat vocal folds. In vitro, TGF-\u03b21 activated YAP and TAZ in human VF fibroblasts, and inhibition of YAP\/TAZ reversed TGF-\u03b21-stimulated fibroplastic gene upregulation. Additionally, TGF-\u03b21 induced localization of YAP and TAZ in close proximity to SMAD2\/3, and nuclear accumulation of SMAD2\/3 was inhibited by a YAP\/TAZ inhibitor. Collectively, YAP and TAZ were synergistically activated with the TGF-\u03b2\/SMAD pathway, and likely essential for the fibroplastic phenotypic shift in VF fibroblasts. Based on these data, YAP\/TAZ may evolve as an attractive therapeutic target for VF fibrosis.<\/jats:p>","DOI":"10.1038\/s41598-021-92871-z","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T10:07:24Z","timestamp":1624961244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Concurrent YAP\/TAZ and SMAD signaling mediate vocal fold fibrosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Ryosuke","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Hiwatashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Bing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina P.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Branski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"92871_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/000348940711600604","volume":"116","author":"N Welham","year":"2007","unstructured":"Welham, N., Dailey, S., Ford, C. & Bless, D. Voice handicap evaluation of patients with pathologic sulcus vocalis. Ann. Otol. Rhinol. Laryngol. 116, 411\u2013417 (2007).","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"92871_CR2","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1097\/00005537-200409000-00009","volume":"114","author":"CA Rosen","year":"2004","unstructured":"Rosen, C. A., Lee, A. S., Osborne, J., Zullo, T. & Murry, T. Development and validation of the voice handicap index-10. Laryngoscope 114, 1549\u20131556 (2004).","journal-title":"Laryngoscope"},{"key":"92871_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/000348940611500209","volume":"115","author":"SM Cohen","year":"2006","unstructured":"Cohen, S. M., Dupont, W. D. & Courey, M. S. Quality-of-life impact of non-neoplastic voice disorders: a meta-analysis. Ann. Otol. Rhinol. Laryngol. 115, 128\u2013134 (2006).","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"92871_CR4","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/lary.23189","volume":"122","author":"SM Cohen","year":"2012","unstructured":"Cohen, S. M., Kim, J. W., Roy, N., Asche, C. & Courey, M. Direct health care costs of laryngeal diseases and disorders. Laryngoscope 122, 1582\u20131588 (2012).","journal-title":"Laryngoscope"},{"key":"92871_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/000348941011900513","volume":"119","author":"B Vyas","year":"2010","unstructured":"Vyas, B., Ishikawa, K., Duflo, S., Chen, X. & Thibeault, S. L. Inhibitory effects of hepatocyte growth factor and interleukin-6 on transforming growth factor-beta1 mediated vocal fold fibroblast-myofibroblast differentiation. Ann. Otol. Rhinol. Laryngol. 119, 350\u2013357. https:\/\/doi.org\/10.1177\/000348941011900513 (2010).","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"92871_CR6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/lary.23681","volume":"123","author":"ME Jette","year":"2013","unstructured":"Jette, M. E., Hayer, S. D. & Thibeault, S. L. Characterization of human vocal fold fibroblasts derived from chronic scar. Laryngoscope 123, 738\u2013745. https:\/\/doi.org\/10.1002\/lary.23681 (2013).","journal-title":"Laryngoscope"},{"key":"92871_CR7","doi-asserted-by":"publisher","first-page":"E110","DOI":"10.1002\/lary.25581","volume":"126","author":"A Branco","year":"2016","unstructured":"Branco, A., Bartley, S. M., King, S. N., Jette, M. E. & Thibeault, S. L. Vocal fold myofibroblast profile of scarring. Laryngoscope 126, E110-117. https:\/\/doi.org\/10.1002\/lary.25581 (2016).","journal-title":"Laryngoscope"},{"key":"92871_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/labinvest.2016.43","volume":"96","author":"Y Kishimoto","year":"2016","unstructured":"Kishimoto, Y., Kishimoto, A. O., Ye, S., Kendziorski, C. & Welham, N. V. Modeling fibrosis using fibroblasts isolated from scarred rat vocal folds. Lab. Invest. 96, 807\u2013816. https:\/\/doi.org\/10.1038\/labinvest.2016.43 (2016).","journal-title":"Lab. Invest."},{"key":"92871_CR9","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1097\/MLG.0b013e31817d7546","volume":"118","author":"MM Mortensen","year":"2008","unstructured":"Mortensen, M. M. et al. The use of the pulse dye laser in the treatment of vocal fold scar: A preliminary study. Laryngoscope 118, 1884\u20131888 (2008).","journal-title":"Laryngoscope"},{"key":"92871_CR10","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1097\/01.mlg.0000231455.19183.8c","volume":"116","author":"M Mortensen","year":"2006","unstructured":"Mortensen, M. & Woo, P. Office steroid injections of the larynx. Laryngoscope 116, 1735\u20131739 (2006).","journal-title":"Laryngoscope"},{"key":"92871_CR11","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00405-013-2498-9","volume":"270","author":"G Friedrich","year":"2013","unstructured":"Friedrich, G. et al. Vocal fold scars: Current concepts and future directions: Consensus report of the Phonosurgery Committee of the European Laryngological Society. Eur. Arch. Otorhinolaryngol. 270, 2491\u20132507. https:\/\/doi.org\/10.1007\/s00405-013-2498-9 (2013).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"92871_CR12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1177\/0194599816654899","volume":"155","author":"WG Young","year":"2016","unstructured":"Young, W. G. et al. Voice outcomes following a single office-based steroid injection for vocal fold scar. Otolaryngol. Head Neck Surg. 155, 820\u2013828. https:\/\/doi.org\/10.1177\/0194599816654899 (2016).","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"92871_CR13","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/000348940911800902","volume":"118","author":"Y Kishimoto","year":"2009","unstructured":"Kishimoto, Y., Hirano, S., Kojima, T., Kanemaru, S. & Ito, J. Implantation of an atelocollagen sheet for the treatment of vocal fold scarring and sulcus vocalis. Ann. Otol. Rhinol. Laryngol. 118, 613\u2013620. https:\/\/doi.org\/10.1177\/000348940911800902 (2009).","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"92871_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0892-1997(97)80083-5","volume":"11","author":"RT Sataloff","year":"1997","unstructured":"Sataloff, R. T., Spiegel, J. R., Hawkshaw, M., Rosen, D. C. & Heuer, R. J. Autologous fat implantation for vocal fold scar: A preliminary report. J. Voice 11, 238\u2013246 (1997).","journal-title":"J. Voice"},{"key":"92871_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.otohns.2009.12.035","volume":"142","author":"G Molteni","year":"2010","unstructured":"Molteni, G. et al. Auto-crosslinked hyaluronan gel injections in phonosurgery. Otolaryngol. Head Neck Surg. 142, 547\u2013553. https:\/\/doi.org\/10.1016\/j.otohns.2009.12.035 (2010).","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"92871_CR16","doi-asserted-by":"publisher","first-page":"E338","DOI":"10.1002\/lary.25315","volume":"125","author":"T Kanazawa","year":"2015","unstructured":"Kanazawa, T. et al. Single injection of basic fibroblast growth factor to treat severe vocal fold lesions and vocal fold paralysis. Laryngoscope 125, E338-344. https:\/\/doi.org\/10.1002\/lary.25315 (2015).","journal-title":"Laryngoscope"},{"key":"92871_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/term.2603","volume":"12","author":"S Hirano","year":"2018","unstructured":"Hirano, S. et al. A phase I\/II exploratory clinical trial for intracordal injection of recombinant hepatocyte growth factor for vocal fold scar and sulcus. J. Tissue Eng. Regen. Med. 12, 1031\u20131038. https:\/\/doi.org\/10.1002\/term.2603 (2018).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"92871_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13287-018-0842-0","volume":"9","author":"A Mattei","year":"2018","unstructured":"Mattei, A. et al. Autologous adipose-derived stromal vascular fraction and scarred vocal folds: first clinical case report. Stem. Cell Res. Ther. 9, 202. https:\/\/doi.org\/10.1186\/s13287-018-0842-0 (2018).","journal-title":"Stem. Cell Res. Ther."},{"key":"92871_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021873","author":"M Morikawa","year":"2016","unstructured":"Morikawa, M., Derynck, R. & Miyazono, K. TGF-beta and the TGF-beta family: Context-dependent roles in cell and tissue physiology. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a021873 (2016).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"92871_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jcp.25879","volume":"233","author":"JM Carthy","year":"2018","unstructured":"Carthy, J. M. TGFbeta signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders. J. Cell Physiol. 233, 98\u2013106. https:\/\/doi.org\/10.1002\/jcp.25879 (2018).","journal-title":"J. Cell Physiol."},{"key":"92871_CR21","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1002\/lary.24723","volume":"124","author":"BC Paul","year":"2014","unstructured":"Paul, B. C. et al. Smad3: An emerging target for vocal fold fibrosis. Laryngoscope 124, 2231\u20132237 (2014).","journal-title":"Laryngoscope"},{"key":"92871_CR22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/lary.25673","volume":"126","author":"RC Branski","year":"2016","unstructured":"Branski, R. C., Bing, R., Kraja, I. & Amin, M. R. The role of Smad3 in the fibrotic phenotype in human vocal fold fibroblasts. Laryngoscope 126, 1151\u20131156 (2016).","journal-title":"Laryngoscope"},{"key":"92871_CR23","doi-asserted-by":"publisher","first-page":"E308","DOI":"10.1002\/lary.26648","volume":"127","author":"N Hiwatashi","year":"2017","unstructured":"Hiwatashi, N. et al. SMAD3 expression and regulation of fibroplasia in vocal fold injury. Laryngoscope 127, E308\u2013E316. https:\/\/doi.org\/10.1002\/lary.26648 (2017).","journal-title":"Laryngoscope"},{"key":"92871_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/s0092-8674(03)00557-9","volume":"114","author":"KF Harvey","year":"2003","unstructured":"Harvey, K. F., Pfleger, C. M. & Hariharan, I. K. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114, 457\u2013467. https:\/\/doi.org\/10.1016\/s0092-8674(03)00557-9 (2003).","journal-title":"Cell"},{"key":"92871_CR25","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1101\/gad.1134003","volume":"17","author":"J Jia","year":"2003","unstructured":"Jia, J., Zhang, W., Wang, B., Trinko, R. & Jiang, J. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 17, 2514\u20132519. https:\/\/doi.org\/10.1101\/gad.1134003 (2003).","journal-title":"Genes Dev."},{"key":"92871_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/ncb1051","volume":"5","author":"S Pantalacci","year":"2003","unstructured":"Pantalacci, S., Tapon, N. & Leopold, P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat. Cell Biol. 5, 921\u2013927. https:\/\/doi.org\/10.1038\/ncb1051 (2003).","journal-title":"Nat. Cell Biol."},{"key":"92871_CR27","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/ncb1050","volume":"5","author":"RS Udan","year":"2003","unstructured":"Udan, R. S., Kango-Singh, M., Nolo, R., Tao, C. & Halder, G. Hippo promotes proliferation arrest and apoptosis in the Salvador\/Warts pathway. Nat. Cell Biol. 5, 914\u2013920. https:\/\/doi.org\/10.1038\/ncb1050 (2003).","journal-title":"Nat. Cell Biol."},{"key":"92871_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s0092-8674(03)00549-x","volume":"114","author":"S Wu","year":"2003","unstructured":"Wu, S., Huang, J., Dong, J. & Pan, D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114, 445\u2013456. https:\/\/doi.org\/10.1016\/s0092-8674(03)00549-x (2003).","journal-title":"Cell"},{"key":"92871_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ceb.2017.12.012","volume":"49","author":"V Fu","year":"2017","unstructured":"Fu, V., Plouffe, S. W. & Guan, K. L. The Hippo pathway in organ development, homeostasis, and regeneration. Curr. Opin. Cell Biol. 49, 99\u2013107. https:\/\/doi.org\/10.1016\/j.ceb.2017.12.012 (2017).","journal-title":"Curr. Opin. Cell Biol."},{"key":"92871_CR30","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/onc.2011.363","volume":"31","author":"A Mauviel","year":"2012","unstructured":"Mauviel, A., Nallet-Staub, F. & Varelas, X. Integrating developmental signals: A Hippo in the (path)way. Oncogene 31, 1743\u20131756. https:\/\/doi.org\/10.1038\/onc.2011.363 (2012).","journal-title":"Oncogene"},{"key":"92871_CR31","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1101\/gad.219402.113","volume":"27","author":"FX Yu","year":"2013","unstructured":"Yu, F. X. et al. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 27, 1223\u20131232. https:\/\/doi.org\/10.1101\/gad.219402.113 (2013).","journal-title":"Genes Dev."},{"key":"92871_CR32","doi-asserted-by":"publisher","first-page":"58315","DOI":"10.18632\/oncotarget.11089","volume":"7","author":"K Zhang","year":"2016","unstructured":"Zhang, K. et al. G-protein-coupled receptors mediate omega-3 PUFAs-inhibited colorectal cancer by activating the Hippo pathway. Oncotarget 7, 58315\u201358330. https:\/\/doi.org\/10.18632\/oncotarget.11089 (2016).","journal-title":"Oncotarget"},{"key":"92871_CR33","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1158\/0008-5472.can-16-3229","volume":"77","author":"Z Wang","year":"2017","unstructured":"Wang, Z. et al. Endothelin promotes colorectal tumorigenesis by activating YAP\/TAZ. Cancer Res. 77, 2413\u20132423. https:\/\/doi.org\/10.1158\/0008-5472.can-16-3229 (2017).","journal-title":"Cancer Res."},{"key":"92871_CR34","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.1038\/ncomms7239","volume":"6","author":"H Wu","year":"2015","unstructured":"Wu, H. et al. Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis. Nat. Commun. 6, 6239. https:\/\/doi.org\/10.1038\/ncomms7239 (2015).","journal-title":"Nat. Commun."},{"key":"92871_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","volume":"63","author":"I Mannaerts","year":"2015","unstructured":"Mannaerts, I. et al. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. J. Hepatol. 63, 679\u2013688. https:\/\/doi.org\/10.1016\/j.jhep.2015.04.011 (2015).","journal-title":"J. Hepatol."},{"key":"92871_CR36","doi-asserted-by":"publisher","first-page":"31931","DOI":"10.1038\/srep31931","volume":"6","author":"E Seo","year":"2016","unstructured":"Seo, E. et al. The Hippo-Salvador signaling pathway regulates renal tubulointerstitial fibrosis. Sci. Rep. 6, 31931. https:\/\/doi.org\/10.1038\/srep31931 (2016).","journal-title":"Sci. Rep."},{"key":"92871_CR37","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.4161\/cc.21397","volume":"11","author":"M Fujii","year":"2012","unstructured":"Fujii, M. et al. Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFbeta signaling and defects in the Hippo signaling cascade. Cell Cycle 11, 3373\u20133379. https:\/\/doi.org\/10.4161\/cc.21397 (2012).","journal-title":"Cell Cycle"},{"key":"92871_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1084\/jem.20111653","volume":"209","author":"M Fujii","year":"2012","unstructured":"Fujii, M. et al. TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J. Exp. Med. 209, 479\u2013494. https:\/\/doi.org\/10.1084\/jem.20111653 (2012).","journal-title":"J. Exp. Med."},{"key":"92871_CR39","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1016\/j.jmb.2015.04.015","volume":"427","author":"K Grannas","year":"2015","unstructured":"Grannas, K. et al. Crosstalk between hippo and TGFbeta: Subcellular localization of YAP\/TAZ\/Smad complexes. J. Mol. Biol. 427, 3407\u20133415. https:\/\/doi.org\/10.1016\/j.jmb.2015.04.015 (2015).","journal-title":"J. Mol. Biol."},{"key":"92871_CR40","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1167\/iovs.18-24258","volume":"59","author":"A Futakuchi","year":"2018","unstructured":"Futakuchi, A. et al. YAP\/TAZ are essential for TGF-beta2-mediated conjunctival fibrosis. Invest. Ophthalmol. Vis. Sci. 59, 3069\u20133078. https:\/\/doi.org\/10.1167\/iovs.18-24258 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"92871_CR41","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ncb1748","volume":"10","author":"X Varelas","year":"2008","unstructured":"Varelas, X. et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat.Cell Biol. 10, 837\u2013848. https:\/\/doi.org\/10.1038\/ncb1748 (2008).","journal-title":"Nat.Cell Biol."},{"key":"92871_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/000348940511400303","volume":"114","author":"T Tateya","year":"2005","unstructured":"Tateya, T., Tateya, I., Sohn, J. H. & Bless, D. M. Histologic characterization of rat vocal fold scarring. Ann. Otol. Rhinol. Laryngol. 114, 183\u2013191. https:\/\/doi.org\/10.1177\/000348940511400303 (2005).","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"92871_CR43","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1177\/000348940911800310","volume":"118","author":"RC Branski","year":"2009","unstructured":"Branski, R. C. et al. Effects of transforming growth factor-beta1 on human vocal fold fibroblasts. Ann. Otol. Rhinol. Laryngol. 118, 218\u2013226. https:\/\/doi.org\/10.1177\/000348940911800310 (2009).","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"92871_CR44","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1158\/0008-5472.CAN-10-2711","volume":"71","author":"D Lai","year":"2011","unstructured":"Lai, D., Ho, K. C., Hao, Y. & Yang, X. Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res. 71, 2728\u20132738. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2711 (2011).","journal-title":"Cancer Res."},{"key":"92871_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13059-021-02272-8","volume":"22","author":"L Li","year":"2021","unstructured":"Li, L. et al. A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis. Genome Biol. 22, 54. https:\/\/doi.org\/10.1186\/s13059-021-02272-8 (2021).","journal-title":"Genome Biol."},{"key":"92871_CR46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.tranon.2014.02.005","volume":"7","author":"U Schutte","year":"2014","unstructured":"Schutte, U. et al. Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma. Transl. Oncol. 7, 309\u2013321. https:\/\/doi.org\/10.1016\/j.tranon.2014.02.005 (2014).","journal-title":"Transl. Oncol."},{"key":"92871_CR47","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu, F. X., Zhao, B. & Guan, K. L. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163, 811\u2013828. https:\/\/doi.org\/10.1016\/j.cell.2015.10.044 (2015).","journal-title":"Cell"},{"key":"92871_CR48","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962\u20131971. https:\/\/doi.org\/10.1101\/gad.1664408 (2008).","journal-title":"Genes Dev."},{"key":"92871_CR49","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2012.191","volume":"32","author":"M Morikawa","year":"2013","unstructured":"Morikawa, M., Koinuma, D., Miyazono, K. & Heldin, C. H. Genome-wide mechanisms of Smad binding. Oncogene 32, 1609\u20131615. https:\/\/doi.org\/10.1038\/onc.2012.191 (2013).","journal-title":"Oncogene"},{"key":"92871_CR50","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s13238-010-0105-z","volume":"1","author":"X Luo","year":"2010","unstructured":"Luo, X. Snapshots of a hybrid transcription factor in the Hippo pathway. Protein Cell 1, 811\u2013819. https:\/\/doi.org\/10.1007\/s13238-010-0105-z (2010).","journal-title":"Protein Cell"},{"key":"92871_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1126\/scisignal.2005096","volume":"7","author":"H Wackerhage","year":"2014","unstructured":"Wackerhage, H., DelRe, D. P., Judson, R. N., Sudol, M. & Sadoshima, J. The Hippo signal transduction network in skeletal and cardiac muscle. Sci. Signal 7, 4. https:\/\/doi.org\/10.1126\/scisignal.2005096 (2014).","journal-title":"Sci. Signal"},{"key":"92871_CR52","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/jid.2013.339","volume":"134","author":"MJ Lee","year":"2014","unstructured":"Lee, M. J., Byun, M. R., Furutani-Seiki, M., Hong, J. H. & Jung, H. S. YAP and TAZ regulate skin wound healing. J. Invest. Dermatol. 134, 518\u2013525. https:\/\/doi.org\/10.1038\/jid.2013.339 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"92871_CR53","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/mp.54.3.180","volume":"54","author":"A Leask","year":"2001","unstructured":"Leask, A. et al. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol. Pathol. 54, 180\u2013183. https:\/\/doi.org\/10.1136\/mp.54.3.180 (2001).","journal-title":"Mol. Pathol."},{"key":"92871_CR54","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1128\/MCB.00615-13","volume":"33","author":"C Parada","year":"2013","unstructured":"Parada, C., Li, J., Iwata, J., Suzuki, A. & Chai, Y. CTGF mediates Smad-dependent transforming growth factor beta signaling to regulate mesenchymal cell proliferation during palate development. Mol. Cell Biol. 33, 3482\u20133493. https:\/\/doi.org\/10.1128\/MCB.00615-13 (2013).","journal-title":"Mol. Cell Biol."},{"key":"92871_CR55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/cr.2008.325","volume":"19","author":"CS Hill","year":"2009","unstructured":"Hill, C. S. Nucleocytoplasmic shuttling of Smad proteins. Cell Res. 19, 36\u201346. https:\/\/doi.org\/10.1038\/cr.2008.325 (2009).","journal-title":"Cell Res."},{"key":"92871_CR56","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong, J. et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120\u20131133. https:\/\/doi.org\/10.1016\/j.cell.2007.07.019 (2007).","journal-title":"Cell"},{"key":"92871_CR57","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","volume":"17","author":"FD Camargo","year":"2007","unstructured":"Camargo, F. D. et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17, 2054\u20132060. https:\/\/doi.org\/10.1016\/j.cub.2007.10.039 (2007).","journal-title":"Curr. Biol."},{"key":"92871_CR58","doi-asserted-by":"publisher","first-page":"14902","DOI":"10.1074\/jbc.M117.780502","volume":"292","author":"MZ Miranda","year":"2017","unstructured":"Miranda, M. Z. et al. TGF-beta1 regulates the expression and transcriptional activity of TAZ protein via a Smad3-independent, myocardin-related transcription factor-mediated mechanism. J. Biol. Chem. 292, 14902\u201314920. https:\/\/doi.org\/10.1074\/jbc.M117.780502 (2017).","journal-title":"J. Biol. Chem."},{"key":"92871_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aax4067","author":"X Yin","year":"2019","unstructured":"Yin, X. et al. Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-beta. Sci. Signal https:\/\/doi.org\/10.1126\/scisignal.aax4067 (2019).","journal-title":"Sci. Signal"},{"key":"92871_CR60","doi-asserted-by":"publisher","first-page":"E317","DOI":"10.1002\/lary.26678","volume":"127","author":"N Hiwatashi","year":"2017","unstructured":"Hiwatashi, N., Bing, R., Kraja, I. & Branski, R. C. NR4A1 is an endogenous inhibitor of vocal fold fibrosis. Laryngoscope 127, E317\u2013E323 (2017).","journal-title":"Laryngoscope"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92871-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92871-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92871-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T10:36:42Z","timestamp":1670063802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92871-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92871"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92871-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"17 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13484"}}